Axogen, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
AXGN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
13631 Progress Blvd., Suite 400, Alachua, FL

Insiders trading volume in the past year

Axogen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Karen L. Zaderej CEO, Director $8.78M -$302K -3.32% Mar 16, 2024
Michael Dale CEO and President, Director $3.46M Aug 9, 2024
Mark Gold Director $2.45M Jun 1, 2022
Gregory Gene Freitag Director $2.32M -$225K -8.84% Jun 4, 2024
Nir Naor Cfo $2.25M Jan 1, 2024
Erick DeVinney Chief Innovation Officer $1.98M -$35.2K -1.75% Mar 16, 2024
Peter J. Mariani EVP & Chief Financial Officer $1.9M -$93.8K -4.7% Dec 11, 2023
Eric Sandberg Chief Commercial Officer $1.22M Jul 18, 2022
Guido J. Neels Director $1M Sep 1, 2024
Amy Wendell Director $917K Sep 1, 2024
Mark Friedman VP Regulatory Affairs & Policy $797K Mar 16, 2022
Jens Kemp Chief Marketing Officer $740K Feb 22, 2024
Kathy Weiler Director $700K Jun 6, 2024
Maria D. Martinez Chief Human Resources Officer $695K Jul 18, 2023
Alan M. Levine Director $619K Sep 1, 2024
Michael Patrick Donovan VP Operations $581K -$366K -38.7% Mar 16, 2024
John Johnson Director $528K Sep 1, 2024
Marc A. Began EVP and General Counsel $515K Feb 22, 2024
Joseph A. Tyndall Director $479K Sep 1, 2024
Angelo Scopelianos Chief R&D Officer $445K -$52.8K -10.6% Mar 16, 2024
Paul Thomas Director $409K Sep 1, 2024
Isabelle Billet Chief Strategy and BD Officer $383K Dec 27, 2022
William Burke Director $383K Sep 1, 2024
Quentin S. Blackford Director $247K Mar 30, 2022
Bradley Ottinger General Counsel and CCO $200K Mar 16, 2023

Recent Insider Transactions by Companies or Individuals for Axogen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.